Postoperative adjuvant therapy following radical resection for intrahepatic cholangiocarcinoma: A multicenter retrospective study

The prognosis of intrahepatic cholangiocarcinoma (ICC) after radical resection is far from satisfactory; however, the clinical value of adjuvant therapy (AT) remains controversial. This multicenter study aimed to evaluate the clinical value of AT and identify potential patients who would be benefited from AT.

[1]  K. Lillemoe,et al.  Predictors of adjuvant treatment and survival in patients with intrahepatic cholangiocarcinoma who undergo resection. , 2019, American journal of surgery.

[2]  C. Carnaghi,et al.  Adjuvant chemotherapy in resected bile duct cancer: A systematic review and meta-analysis of randomized trials. , 2019, Critical reviews in oncology/hematology.

[3]  C. la Vecchia,et al.  Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma. , 2019, Journal of hepatology.

[4]  Yajin Chen,et al.  Is lymph node dissection necessary for resectable intrahepatic cholangiocarcinoma? A systematic review and meta-analysis. , 2019, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[5]  Y. Shioyama,et al.  Carbon-ion radiotherapy for cholangiocarcinoma: a multi-institutional study by and the Japan carbon-ion radiation oncology study group (J-CROS) , 2019, Oncotarget.

[6]  J. Sicklick,et al.  NCCN Guidelines Insights: Hepatobiliary Cancers, Version 2.2019: Featured Updates to the NCCN Guidelines , 2019 .

[7]  J. Sicklick,et al.  Guidelines Insights: Hepatobiliary Cancers, Version 2.2019. , 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

[8]  F. Shen,et al.  [Progress on surgical treatment of intrahepatic cholangiocarcinoma]. , 2019, Zhonghua wai ke za zhi [Chinese journal of surgery].

[9]  Chen-hai Liu,et al.  The effect of adjuvant chemotherapy in resectable cholangiocarcinoma: A meta-analysis and systematic review. , 2019, Hepatobiliary & pancreatic diseases international : HBPD INT.

[10]  S. Maithel,et al.  Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  O. Riesterer,et al.  Stereotactic body radiotherapy dose and its impact on local control and overall survival of patients for locally advanced intrahepatic and extrahepatic cholangiocarcinoma. , 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[12]  C. Lo,et al.  Adjuvant chemotherapy improves oncological outcomes of resectable intrahepatic cholangiocarcinoma , 2019, Medicine.

[13]  Ya Cao,et al.  Systemic inflammation score predicts survival in patients with intrahepatic cholangiocarcinoma undergoing curative resection , 2019, Journal of Cancer.

[14]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[15]  Bo Chen,et al.  Benefit of adjuvant radiotherapy following narrow-margin hepatectomy in patients with intrahepatic cholangiocarcinoma that adhere to major vessels , 2018, Cancer management and research.

[16]  Szu-Yuan Wu,et al.  Outcomes of adjuvant treatments for resectable intrahepatic cholangiocarcinoma: Chemotherapy alone, sequential chemoradiotherapy, or concurrent chemoradiotherapy. , 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[17]  S. Curley,et al.  The role of surgery and adjuvant therapy in lymph node–positive cancers of the gallbladder and intrahepatic bile ducts , 2018, Cancer.

[18]  Ya Cao,et al.  Intrahepatic cholangiocarcinoma patients without indications of lymph node metastasis not benefit from lymph node dissection , 2017, Oncotarget.

[19]  Y. Morine,et al.  Effect of Adjuvant Gemcitabine Combined with Low-dose 5-Fluorouracil and Cisplatin Chemotherapy for Advanced Biliary Carcinoma. , 2017, Anticancer research.

[20]  A. Ejaz,et al.  Impact of adjuvant chemotherapy on survival in patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis. , 2017, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[21]  Q. Xia,et al.  Transarterial Chemoembolization: A Favorable Postoperative Management to Improve Prognosis of Hepatitis B Virus-associated Intrahepatic Cholangiocarcinoma after Surgical Resection , 2017, International journal of biological sciences.

[22]  W. Lau,et al.  Actual over 10-year survival after liver resection for patients with intrahepatic cholangiocarcinoma , 2017, Oncotarget.

[23]  M. Manns,et al.  The effect of adjuvant chemotherapy in patients with intrahepatic cholangiocarcinoma: a matched pair analysis , 2017, Journal of Cancer Research and Clinical Oncology.

[24]  T. Pawlik,et al.  Is Radiotherapy Warranted Following Intrahepatic Cholangiocarcinoma Resection? The Impact of Surgical Margins and Lymph Node Status on Survival , 2016, Annals of Surgical Oncology.

[25]  Dong-hao Wu,et al.  Adjuvant Transarterial Chemoembolization Following Liver Resection for Intrahepatic Cholangiocarcinoma Based on Survival Risk Stratification. , 2015, The oncologist.

[26]  T. Pawlik,et al.  Chemotherapy for Surgically Resected Intrahepatic Cholangiocarcinoma , 2015, Annals of Surgical Oncology.

[27]  Q. Ye,et al.  Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection , 2014, Liver international : official journal of the International Association for the Study of the Liver.

[28]  Rui-qing Liu,et al.  Prognosis of the intrahepatic cholangiocarcinoma after resection: hepatitis B virus infection and adjuvant chemotherapy are favorable prognosis factors , 2013, Cancer Cell International.

[29]  T. Pawlik,et al.  Intra-arterial Therapy for Advanced Intrahepatic Cholangiocarcinoma: A Multi-institutional Analysis , 2013, Annals of Surgical Oncology.

[30]  N. Yang,et al.  Postoperative adjuvant transcatheter arterial chemoembolisation improves survival of intrahepatic cholangiocarcinoma patients with poor prognostic factors: results of a large monocentric series. , 2012, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[31]  Jiamei Yang,et al.  Adjuvant Transcatheter Arterial Chemoembolization for Intrahepatic Cholangiocarcinoma after Curative Surgery: Retrospective Control Study , 2011, World Journal of Surgery.

[32]  I-S Lee,et al.  Transarterial chemoembolization versus supportive therapy in the palliative treatment of unresectable intrahepatic cholangiocarcinoma. , 2011, Clinical radiology.

[33]  Zhao-You Tang,et al.  Benefit of radiotherapy for 90 patients with resected intrahepatic cholangiocarcinoma and concurrent lymph node metastases , 2010, Journal of Cancer Research and Clinical Oncology.